Thursday, March 28, 2024

CATEGORY

News

Precision price-targeting at Cannaray CBD’s two new stockists, Debenhams and Morrisons

Cannaray CBD has added two household-name retailers to its list of stockists in the past week: Debenhams today and Morrisons. The retailers are selling...

Power to the Parish—will Jersey keep low-level class B and C drug offending out of the courts?

Cannabis campaigners in Jersey are waiting to see if the island’s government will go ahead with a long-planned change in approach to people found...

Class A confusion as Conservative crime commissioners call for clarity on cannabis

Conservative police and crime commissioners (PCCs) at this week’s party conference in Birmingham have called for cannabis to be rescheduled as a class A...

Canada and California build up the learning curve of legalising cannabis and disrupting illicit drugs

While ‘first mover’ status has its advantages, perils and pitfalls abound in uncharted territory. This has been particularly true for countries and states legalising...

Voyager’s response to the cost of living and climate crises brings CBD to new customers

Affordability and CBD—two words not often heard together, especially when teamed with ‘under £10’. This, however,  is one of the twin drivers for Scottish...

Patients, patience and perseverance: the CIC’s plan to boost the UK cannabis industry

The Cannabis Industry Council (CIC) has completed its first annual report. Following its publication, the CIC's new CEO, Mike Morgan-Giles, outlines the organisation’s priorities...

New health secretary, new approach to medicinal cannabis?

Sorting out the shortcomings in the NHS prescribing system for medicinal cannabis—which allows but rarely enables patients to get prescriptions—is going to take tenacity and...

Dear Rishi, dear Liz… industry makes the case for a cannabis Brexit dividend

The two candidates in the Conservative party leadership election were sent open letters this week outlining the opportunities which a better-regulated cannabis industry might...

CBMP: three NHS prescriptions v 279,000 Australian approvals—what can the UK learn from Australia’s regulators?

The opening of a clinic in a shopping centre in Adelaide at which two GPs can prescribe medicinal cannabis alongside other alternative therapies has...

A drink for your journey? TRIP’s £10m fundraise

£10 million of investment has been secured by Trip CBD, a UK-based CBD drinks and oils brand, in its latest funding round according to...